The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tigges, M. A.
Right arrow Articles by Burke, R. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tigges, M. A.
Right arrow Articles by Burke, R. L.
Right arrowPubmed/NCBI databases
*Protein
*Substance via MeSH

The Journal of Immunology, Vol 156, Issue 10 3901-3910, Copyright © 1996 by American Association of Immunologists


ARTICLES

Human herpes simplex virus (HSV)-specific CD8+ CTL clones recognize HSV- 2-infected fibroblasts after treatment with IFN-gamma or when virion host shutoff functions are disabled

MA Tigges, S Leng, DC Johnson and RL Burke
Chiron Corporation, Emeryville, CA 94608, USA.

Herpes simplex virus (HSV)-specific CD8+ CTL cloned from individuals infected with HSV-2 efficiently lyse HSV-infected EBV-transformed B lymphoblastoid cells; however, these same CTL fail to lyse infected dermal fibroblasts. By 3 h after infection (early), class I MHC expression is reduced to less than 20% of that in uninfected fibroblasts, and expression is further reduced to less than 1% of the level in uninfected cells between 6 and 18 h after infection (late). We used an HSV-2 mutant that lacked the virion host shutoff (vhs) function to demonstrate that vhs plays a role in the loss of class I expression. While fibroblasts infected with this mutant are lysed by CTL that recognize virion proteins presented early as a consequence of introduction into the cytoplasm by the infecting virus, they are resistant to lysis by CTL that recognize viral proteins that must be synthesized de novo to be presented as class I Ags. Fibroblasts infected with a mutant that lacks the transporter-associated protein inhibitor ICP47 and is partially vhs defective are sensitive to CTL lysis. Pretreatment of fibroblasts with IFN-gamma prior to HSV infection sustained the level of class I expression for longer periods after infection, and these fibroblasts, infected with wild-type HSV-2, were partially sensitive to lysis by HSV-specific CTL. Taken together, these results suggest that the combined effects of the HSV-2 vhs and ICP47 gene products are to block Ag presentation by class I MHC. However, this effect can be transiently counteracted by IFN-gamma providing an early role for CD8+ CTL in the cellular immune response to HSV-2.


This article has been cited by other articles:


Home page
J. Virol.Home page
G. Zahariadis, M. J. Wagner, R. C. Doepker, J. M. Maciejko, C. M. Crider, K. R. Jerome, and J. R. Smiley
Cell-Type-Specific Tyrosine Phosphorylation of the Herpes Simplex Virus Tegument Protein VP11/12 Encoded by Gene UL46
J. Virol., July 1, 2008; 82(13): 6098 - 6108.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
N. Sarma, D. Agarwal, L. A. Shiflett, and G. S. Read
Small Interfering RNAs That Deplete the Cellular Translation Factor eIF4H Impede mRNA Degradation by the Virion Host Shutoff Protein of Herpes Simplex Virus
J. Virol., July 1, 2008; 82(13): 6600 - 6609.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
T. J. Pasieka, B. Lu, S. D. Crosby, K. M. Wylie, L. A. Morrison, D. E. Alexander, V. D. Menachery, and D. A. Leib
Herpes Simplex Virus Virion Host Shutoff Attenuates Establishment of the Antiviral State
J. Virol., June 1, 2008; 82(11): 5527 - 5535.
[Abstract] [Full Text] [PDF]


Home page
CVIHome page
D. M. Koelle, A. Magaret, C. L. McClurkan, M. L. Remington, T. Warren, F. Teofilovici, and A. Wald
Phase I Dose-Escalation Study of a Monovalent Heat Shock Protein 70-Herpes Simplex Virus Type 2 (HSV-2) Peptide-Based Vaccine Designed To Prime or Boost CD8 T-Cell Responses in HSV-Naive and HSV-2-Infected Subjects
Clin. Vaccine Immunol., May 1, 2008; 15(5): 773 - 782.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
J. Zuo, W. Thomas, D. van Leeuwen, J. M. Middeldorp, E. J. H. J. Wiertz, M. E. Ressing, and M. Rowe
The DNase of Gammaherpesviruses Impairs Recognition by Virus-Specific CD8+ T Cells through an Additional Host Shutoff Function
J. Virol., March 1, 2008; 82(5): 2385 - 2393.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. A. Chentoufi, X. Zhang, K. Lamberth, G. Dasgupta, I. Bettahi, A. Nguyen, M. Wu, X. Zhu, A. Mohebbi, S. Buus, et al.
HLA-A*0201-Restricted CD8+ Cytotoxic T Lymphocyte Epitopes Identified from Herpes Simplex Virus Glycoprotein D
J. Immunol., January 1, 2008; 180(1): 426 - 437.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
A. J. Eisfeld, M. B. Yee, A. Erazo, A. Abendroth, and P. R. Kinchington
Downregulation of Class I Major Histocompatibility Complex Surface Expression by Varicella-Zoster Virus Involves Open Reading Frame 66 Protein Kinase-Dependent and -Independent Mechanisms
J. Virol., September 1, 2007; 81(17): 9034 - 9049.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
A. D. Hislop, M. E. Ressing, D. van Leeuwen, V. A. Pudney, D. Horst, D. Koppers-Lalic, N. P. Croft, J. J. Neefjes, A. B. Rickinson, and E. J.H.J. Wiertz
A CD8+ T cell immune evasion protein specific to Epstein-Barr virus and its close relatives in Old World primates
J. Exp. Med., August 6, 2007; 204(8): 1863 - 1873.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
E. J. Wiertz, R. Devlin, H. L. Collins, and M. E. Ressing
Herpesvirus Interference with Major Histocompatibility Complex Class II-Restricted T-Cell Activation
J. Virol., May 1, 2007; 81(9): 4389 - 4396.
[Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Rowe, B. Glaunsinger, D. van Leeuwen, J. Zuo, D. Sweetman, D. Ganem, J. Middeldorp, E. J. H. J. Wiertz, and M. E. Ressing
Host shutoff during productive Epstein-Barr virus infection is mediated by BGLF5 and may contribute to immune evasion
PNAS, February 27, 2007; 104(9): 3366 - 3371.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
N. Hosken, P. McGowan, A. Meier, D. M. Koelle, P. Sleath, F. Wagener, M. Elliott, K. Grabstein, C. Posavad, and L. Corey
Diversity of the CD8+ T-Cell Response to Herpes Simplex Virus Type 2 Proteins among Persons with Genital Herpes.
J. Virol., June 1, 2006; 80(11): 5509 - 5515.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
P. Feng, D. N. Everly Jr., and G. S. Read
mRNA Decay during Herpes Simplex Virus (HSV) Infections: Protein-Protein Interactions Involving the HSV Virion Host Shutoff Protein and Translation Factors eIF4H and eIF4A
J. Virol., August 1, 2005; 79(15): 9651 - 9664.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
W.-L. Hsu, H. A. Saffran, and J. R. Smiley
Herpes Simplex Virus Infection Stabilizes Cellular IEX-1 mRNA
J. Virol., April 1, 2005; 79(7): 4090 - 4098.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
S. S. Strand and D. A. Leib
Role of the VP16-Binding Domain of vhs in Viral Growth, Host Shutoff Activity, and Pathogenesis
J. Virol., December 15, 2004; 78(24): 13562 - 13572.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
R. C. Doepker, W.-L. Hsu, H. A. Saffran, and J. R. Smiley
Herpes Simplex Virus Virion Host Shutoff Protein Is Stimulated by Translation Initiation Factors eIF4B and eIF4H
J. Virol., May 1, 2004; 78(9): 4684 - 4699.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
J. R. Smiley
Herpes Simplex Virus Virion Host Shutoff Protein: Immune Evasion Mediated by a Viral RNase?
J. Virol., February 1, 2004; 78(3): 1063 - 1068.
[Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
D. M. Koelle, Z. Liu, C. L. McClurkan, R. C. Cevallos, J. Vieira, N. A. Hosken, C. A. Meseda, D. C. Snow, A. Wald, and L. Corey
Immunodominance among herpes simplex virus-specific CD8 T cells expressing a tissue-specific homing receptor
PNAS, October 28, 2003; 100(22): 12899 - 12904.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
J. A. Murphy, R. J. Duerst, T. J. Smith, and L. A. Morrison
Herpes Simplex Virus Type 2 Virion Host Shutoff Protein Regulates Alpha/Beta Interferon but Not Adaptive Immune Responses during Primary Infection In Vivo
J. Virol., September 1, 2003; 77(17): 9337 - 9345.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
L. Samady, E. Costigliola, L. MacCormac, Y. McGrath, S. Cleverley, C. E. Lilley, J. Smith, D. S. Latchman, B. Chain, and R. S. Coffin
Deletion of the Virion Host Shutoff Protein (vhs) from Herpes Simplex Virus (HSV) Relieves the Viral Block to Dendritic Cell Activation: Potential of vhs- HSV Vectors for Dendritic Cell-Mediated Immunotherapy
J. Virol., March 15, 2003; 77(6): 3768 - 3776.
[Abstract] [Full Text] [PDF]


Home page
Clin. Microbiol. Rev.Home page
D. M. Koelle and L. Corey
Recent Progress in Herpes Simplex Virus Immunobiology and Vaccine Research
Clin. Microbiol. Rev., January 1, 2003; 16(1): 96 - 113.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
T. L. Keadle, K. A. Laycock, J. L. Morris, D. A. Leib, L. A. Morrison, J. S. Pepose, and P. M. Stuart
Therapeutic vaccination with vhs- herpes simplex virus reduces the severity of recurrent herpetic stromal keratitis in mice
J. Gen. Virol., October 1, 2002; 83(10): 2361 - 2365.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
D. N. Everly Jr., P. Feng, I. S. Mian, and G. S. Read
mRNA Degradation by the Virion Host Shutoff (Vhs) Protein of Herpes Simplex Virus: Genetic and Biochemical Evidence that Vhs Is a Nuclease
J. Virol., July 29, 2002; 76(17): 8560 - 8571.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
T. L. Keadle, L. A. Morrison, J. L. Morris, J. S. Pepose, and P. M. Stuart
Therapeutic Immunization with a Virion Host Shutoff-Defective, Replication-Incompetent Herpes Simplex Virus Type 1 Strain Limits Recurrent Herpetic Ocular Infection
J. Virol., March 19, 2002; 76(8): 3615 - 3625.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
T. J. Smith, L. A. Morrison, and D. A. Leib
Pathogenesis of Herpes Simplex Virus Type 2 Virion Host Shutoff (vhs) Mutants
J. Virol., March 1, 2002; 76(5): 2054 - 2061.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
D. Koppers-Lalic, F. A. M. Rijsewijk, S. B. E. Verschuren, J. A. M. van Gaans-van den Brink, A. Neisig, M. E. Ressing, J. Neefjes, and E. J. H. J. Wiertz
The UL41-encoded virion host shutoff (vhs) protein and vhs-independent mechanisms are responsible for down-regulation of MHC class I molecules by bovine herpesvirus 1
J. Gen. Virol., September 1, 2001; 82(9): 2071 - 2081.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. M. Koelle, H. B. Chen, M. A. Gavin, A. Wald, W. W. Kwok, and L. Corey
CD8 CTL from Genital Herpes Simplex Lesions: Recognition of Viral Tegument and Immediate Early Proteins and Lysis of Infected Cutaneous Cells
J. Immunol., March 15, 2001; 166(6): 4049 - 4058.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
K. H. Edelmann and C. B. Wilson
Role of CD28/CD80-86 and CD40/CD154 Costimulatory Interactions in Host Defense to Primary Herpes Simplex Virus Infection
J. Virol., January 15, 2001; 75(2): 612 - 621.
[Abstract] [Full Text]


Home page
J. Virol.Home page
B. J. Geiss, T. J. Smith, D. A. Leib, and L. A. Morrison
Disruption of Virion Host Shutoff Activity Improves the Immunogenicity and Protective Capacity of a Replication-Incompetent Herpes Simplex Virus Type 1 Vaccine Strain
J. Virol., December 1, 2000; 74(23): 11137 - 11144.
[Abstract] [Full Text]


Home page
J. Virol.Home page
J.-I. Sin, J. J. Kim, C. Pachuk, C. Satishchandran, and D. B. Weiner
DNA Vaccines Encoding Interleukin-8 and RANTES Enhance Antigen-Specific Th1-Type CD4+ T-Cell-Mediated Protective Immunity against Herpes Simplex Virus Type 2 In Vivo
J. Virol., December 1, 2000; 74(23): 11173 - 11180.
[Abstract] [Full Text]


Home page
J. Immunol.Home page
H. Tsunobuchi, H. Nishimura, F. Goshima, T. Daikoku, Y. Nishiyama, and Y. Yoshikai
Memory-Type CD8+ T Cells Protect IL-2 Receptor {alpha}-Deficient Mice from Systemic Infection with Herpes Simplex Virus Type 2
J. Immunol., October 15, 2000; 165(8): 4552 - 4560.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
T. J. Smith, C. E. Ackland-Berglund, and D. A. Leib
Herpes Simplex Virus Virion Host Shutoff (vhs) Activity Alters Periocular Disease in Mice
J. Virol., April 15, 2000; 74(8): 3598 - 3604.
[Abstract] [Full Text]


Home page
J. Virol.Home page
D. N. Everly Jr. and G. S. Read
Site-Directed Mutagenesis of the Virion Host Shutoff Gene (UL41) of Herpes Simplex Virus (HSV): Analysis of Functional Differences between HSV Type 1 (HSV-1) and HSV-2 Alleles
J. Virol., November 1, 1999; 73(11): 9117 - 9129.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
J.-I. Sin, V. Ayyavoo, J. Boyer, J. Kim, R. B. Ciccarelli, and D. B. Weiner
Protective immune correlates can segregate by vaccine type in a murine herpes model system
Int. Immunol., November 1, 1999; 11(11): 1763 - 1773.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
M. T. C. Winkler, A. Doster, and C. Jones
Bovine Herpesvirus 1 Can Infect CD4+ T Lymphocytes and Induce Programmed Cell Death during Acute Infection of Cattle
J. Virol., October 1, 1999; 73(10): 8657 - 8668.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
R. L. Sparks-Thissen and L. W. Enquist
Differential Regulation of Dk and Kk Major Histocompatibility Complex Class I Proteins on the Cell Surface after Infection of Murine Cells by Pseudorabies Virus
J. Virol., July 1, 1999; 73(7): 5748 - 5756.
[Abstract] [Full Text]


Home page
J. Virol.Home page
A.-X. Holterman, K. Rogers, K. Edelmann, D. M. Koelle, L. Corey, and C. B. Wilson
An Important Role for Major Histocompatibility Complex Class I-Restricted T Cells, and a Limited Role for Gamma Interferon, in Protection of Mice against Lethal Herpes Simplex Virus Infection
J. Virol., March 1, 1999; 73(3): 2058 - 2063.
[Abstract] [Full Text]


Home page
J. Immunol.Home page
J.-I. Sin, J. J. Kim, R. L. Arnold, K. E. Shroff, D. McCallus, C. Pachuk, S. P. McElhiney, M. W. Wolf, S. J. Pompa-de Bruin, T. J. Higgins, et al.
IL-12 Gene as a DNA Vaccine Adjuvant in a Herpes Mouse Model: IL-12 Enhances Th1-Type CD4+ T Cell-Mediated Protective Immunity Against Herpes Simplex Virus-2 Challenge
J. Immunol., March 1, 1999; 162(5): 2912 - 2921.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
D. A. Leib, T. E. Harrison, K. M. Laslo, M. A. Machalek, N. J. Moorman, and H. W. Virgin
Interferons Regulate the Phenotype of  Wild-type and Mutant Herpes Simplex Viruses In Vivo
J. Exp. Med., February 15, 1999; 189(4): 663 - 672.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
D. M. Koelle, J. M. Frank, M. L. Johnson, and W. W. Kwok
Recognition of Herpes Simplex Virus Type 2 Tegument Proteins by CD4 T Cells Infiltrating Human Genital Herpes Lesions
J. Virol., September 1, 1998; 72(9): 7476 - 7483.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
P. Jugovic, A. M. Hill, R. Tomazin, H. Ploegh, and D. C. Johnson
Inhibition of Major Histocompatibility Complex Class I Antigen Presentation in Pig and Primate Cells by Herpes Simplex Virus Type 1 and 2 ICP47
J. Virol., June 1, 1998; 72(6): 5076 - 5084.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1996 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1996 by The American Association of Immunologists, Inc. All rights reserved.